Immunogenetics: Open Access

Immunogenetics: Open Access
Open Access

Commentary - (2022)Volume 7, Issue 6

Anti-Inflammatory Medications of Systemic Lupus Erythematous (SLE)

Sushil Swain*
 
*Correspondence: Sushil Swain, Department of Clinical Hematology and Bone Marrow Transplant, Tata Medical Center, Kolkata, India, Email:

Author info »

Description

Systemic Lupus Erythematous (SLE) is a medical term for lupus, an autoimmune disorder in which of the body immune system unintentionally targets healthy tissue in various body regions. The severity of a person's symptoms can range from mild to severe. Common signs and symptoms include aching and swollen joints, fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, fatigue, and a red rash, which most frequently appears on the face. There are frequently symptom-free intervals known as remissions between episodes of illness known as flares.

It is the outcome of a combination of genetic and environmental factors. There is a 24% chance that the disease will spread to the other identical twin if one twin has it. Other factors thought to raise risk include female sex hormones, sunlight, smoking, vitamin D deficiency, and specific infections. Autoantibodies' immune reaction against a person's own tissues is the mechanism. Inflammation is a common side effect of these antinuclear antibodies. The diagnosis is based on a combination of symptoms and laboratory tests, which can be challenging. In addition to discoid lupus erythematous, neonatal lupus, and sub-acute cutaneous lupus erythematous, there are several other types of lupus erythematous.

There are multiple phenotypes of the illness, and its clinical manifestations range from mild muco cutaneous manifestations to severe central nervous system involvement involving multiple organs. In the emergence of SLE, several immune pathogenic pathways are involved. A number of pathogenic autoantibodies have been precise pathogenesis despite recent advances in technology and our understanding of the pathological basis and risk factors for SLE. A number of classification criteria have been proposed their usefulness in the clinical setting is still up for debate. Diagnosing SLE can be difficult. Organ system involvement dictates how SLE should be managed. Despite the fact that a number of medications have been effective in treating SLE, patients still face a high risk of morbidity and mortality from the condition.

Diagnosis can be challenging because many other diseases alsoexhibit lupus symptoms. Doctor can perform tests to gather the data required to provide a precise diagnosis. More women than men experience SLE. Women may have more severe symptoms both during pregnancy and during their menstrual cycles. Some medical experts think that the female hormone estrogens may contribute to the development of SLE as a result of both of this study.

SLE has no known cure. Treatment aims to reduce symptoms. Depending on the extent of symptoms and the areas of body that SLE affects, treatment may change. The therapies could consist of:

• Anti-inflammatory medications for joint pain and stiffness, such as these options available online

• Steroid creams for rashes

• Corticosteroids to minimize the immune response

• Antimalarial drugs for skin and joint problems

• Disease modifying drugs or targeted immune system agents for more severe cases

Different types of lupus

There are numerous varieties of lupus. The most typical type is systemic lupus erythematous. Additional forms of lupus include:

Cutaneous lupus erythematous: It is known as cutaneous lupus erythematous, and it affects the skin. People who have cutaneous lupus erythematous may have skin problems such rashes and sun sensitivity. The illness may also cause hair loss as a symptom.

Drug-induced lupus: These lupus cases are brought on by particular medications. The symptoms of systemic lupus erythematous may be present in many drug-induced lupus patients, but they are typically transient.

Neonatal lupus: An uncommon form of lupus, neonatal lupus affects newborn children. Neonatal lupus patients have antibodies given to them from their mother, who may have had lupus during her pregnancy or may get the disease later in life. Not all children born to mothers who have lupus will have it. Women, men, kids, and even babies can experience it. About 90% of diagnosed cases are women who are of reproductive age, making women much more likely to experience it than men.

Due to its difficulty in diagnosis, experts have a hard time estimating the number of Americans who have lupus. Numerous symptoms of lupus can potentially be indicators of other medical disorders. Due to this, some lupus patients may live their entire lives without ever receiving a diagnosis. Additionally, lupus is more prevalent in some ethnic groups.

Author Info

Sushil Swain*
 
Department of Clinical Hematology and Bone Marrow Transplant, Tata Medical Center, Kolkata, India
 

Citation: Swain S (2022) Anti-Inflammatory Medications of Systemic Lupus Erythematous (SLE). Immunogenet Open Access. 7:184.

Received: 02-Nov-2022, Manuscript No. IGOA-22-20602; Editor assigned: 04-Nov-2022, Pre QC No. IGOA-22-20602 (PQ); Reviewed: 18-Nov-2022, QC No. IGOA-22-20602; Revised: 25-Nov-2022, Manuscript No. IGOA-22-20602 (R); Published: 02-Dec-2022 , DOI: 10.35248/IGOA.22.7.184

Copyright: © 2022 Swain S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top